Onconetix (ONCO) Receives $1.11M From Warrant Exercise

Go back to Onconetix (ONCO) Receives $1.11M From Warrant Exercise

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

July 11, 2024 8:17 AM EDT

CINCINNATI, Ohio, July 11, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Onconetix or the Company) (Nasdaq: ONCO), today announced it has entered into definitive agreements for the immediate exercise of certain existing warrants to purchase 7,458,642 shares of its common stock originally issued in August 2022 and August 2023, having exercise prices ranging from $1.09 to $2.546 per share, at a reduced exercise price of $0.15 per share. The transaction is expected to close on or about July 12, 2024, subject to satisfaction of customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the... More